RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus-host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703574 | PMC |
| http://dx.doi.org/10.3390/v13122478 | DOI Listing |
Publication Analysis
Top Keywords
immunopathology rsv
4
rsv updated
4
updated review
4
review rsv
4
rsv leading
4
leading respiratory
4
respiratory tract
4
tract disease
4
disease infants
4
infants elderly
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!